Cure My Disease

Don't miss your cure!

 Log in / Sign up

New psoriasis drug shows promise for kids in Head-to-Head trial

NCT ID NCT06425549

Recruiting now Disease control Sponsor: UCB Biopharma SRL Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new medicine called bimekizumab against an existing one (ustekinumab) for children and teens aged 6 to 17 with moderate to severe plaque psoriasis. The goal is to see if bimekizumab works better at clearing skin symptoms. About 168 participants will receive injections and be monitored for improvement and side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE PLAQUE PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ps0021 20033

    RECRUITING

    Nagoya, Japan

  • Ps0021 20071

    RECRUITING

    Nagasaki, Japan

  • Ps0021 20337

    RECRUITING

    Shimotsuga-gun, Japan

  • Ps0021 40023

    COMPLETED

    Erlangen, Germany

  • Ps0021 40085

    ACTIVE_NOT_RECRUITING

    Pisa, Italy

  • Ps0021 40091

    ACTIVE_NOT_RECRUITING

    Nowa Sól, Poland

  • Ps0021 40121

    ACTIVE_NOT_RECRUITING

    Brussels, Belgium

  • Ps0021 40138

    ACTIVE_NOT_RECRUITING

    Bonn, Germany

  • Ps0021 40159

    WITHDRAWN

    Barcelona, Spain

  • Ps0021 40177

    ACTIVE_NOT_RECRUITING

    Münster, Germany

  • Ps0021 40249

    ACTIVE_NOT_RECRUITING

    Kiel, Germany

  • Ps0021 40334

    ACTIVE_NOT_RECRUITING

    Wroclaw, Poland

  • Ps0021 40356

    ACTIVE_NOT_RECRUITING

    Dresden, Germany

  • Ps0021 40420

    WITHDRAWN

    Liège, Belgium

  • Ps0021 40440

    ACTIVE_NOT_RECRUITING

    Ancona, Località Torrette, Italy

  • Ps0021 40515

    COMPLETED

    Berlin, Germany

  • Ps0021 40567

    ACTIVE_NOT_RECRUITING

    Roma, Italy

  • Ps0021 40625

    ACTIVE_NOT_RECRUITING

    Warsaw, Poland

  • Ps0021 40645

    ACTIVE_NOT_RECRUITING

    Frankfurt am Main, Germany

  • Ps0021 40737

    ACTIVE_NOT_RECRUITING

    Rzeszów, Poland

  • Ps0021 40738

    ACTIVE_NOT_RECRUITING

    Wroclaw, Poland

  • Ps0021 40740

    ACTIVE_NOT_RECRUITING

    Bad Bentheim, Germany

  • Ps0021 40741

    ACTIVE_NOT_RECRUITING

    Bialystok, Poland

  • Ps0021 40742

    WITHDRAWN

    Argenteuil, France

  • Ps0021 40743

    ACTIVE_NOT_RECRUITING

    Szczecin, Poland

  • Ps0021 40744

    ACTIVE_NOT_RECRUITING

    Kaposvár, Hungary

  • Ps0021 40745

    ACTIVE_NOT_RECRUITING

    Szeged, Hungary

  • Ps0021 40746

    ACTIVE_NOT_RECRUITING

    Debrecen, Hungary

  • Ps0021 40747

    COMPLETED

    Mainz, Germany

  • Ps0021 40748

    ACTIVE_NOT_RECRUITING

    Plzen-bory, Czechia

  • Ps0021 40749

    ACTIVE_NOT_RECRUITING

    Catania, Italy

  • Ps0021 40750

    ACTIVE_NOT_RECRUITING

    Alicante, Spain

  • Ps0021 40751

    ACTIVE_NOT_RECRUITING

    Esplugues de Llobregat, Spain

  • Ps0021 40752

    COMPLETED

    Granada, Spain

  • Ps0021 40753

    WITHDRAWN

    Santiago de Compostela, Spain

  • Ps0021 40754

    WITHDRAWN

    Nantes, France

  • Ps0021 40758

    ACTIVE_NOT_RECRUITING

    Hamburg, Germany

  • Ps0021 40832

    ACTIVE_NOT_RECRUITING

    Lodz, Poland

  • Ps0021 50084

    ACTIVE_NOT_RECRUITING

    Charleston, South Carolina, 29425, United States

  • Ps0021 50161

    ACTIVE_NOT_RECRUITING

    Los Angeles, California, 90045, United States

  • Ps0021 50162

    ACTIVE_NOT_RECRUITING

    Fountain Valley, California, 92708, United States

  • Ps0021 50196

    COMPLETED

    Northridge, California, 91325, United States

  • Ps0021 50201

    COMPLETED

    Arlington, Texas, 76011, United States

  • Ps0021 50344

    ACTIVE_NOT_RECRUITING

    Indianapolis, Indiana, 46250, United States

  • Ps0021 50355

    ACTIVE_NOT_RECRUITING

    Dallas, Texas, 75235, United States

  • Ps0021 50357

    ACTIVE_NOT_RECRUITING

    St. John's, Canada

  • Ps0021 50581

    WITHDRAWN

    Miami, Florida, 33165, United States

  • Ps0021 50599

    WITHDRAWN

    Kew Gardens, New York, 11415, United States

  • Ps0021 50617

    WITHDRAWN

    St. John's, Canada

  • Ps0021 50618

    ACTIVE_NOT_RECRUITING

    Mississauga, Canada

Conditions

The condition(s) this trial relates to.

psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MODERATE TO SEVERE PLAQUE PSORIASIS